PHARMAKON PRESS

The Journal 'Review of Clinical Pharmacology and Pharmacokinetics-International Edition' (abbreviated title: Rev. Clin. Pharmacol. Pharmacokinet., Int. Ed.) founded in 1987 aims to promote optimum drug therapy by providing original papers and review articles covering important aspects of clinical and applied Pharmacology and Therapeutics, Medicine and Surgery. It became an open access journal in September 2023. The Journal includes drug evaluation reviews providing a detailed focus on different properties, i.e. dosage, toxicology, drugs interactions and place in therapy of both newer and established drugs. Other Review Articles offer state-of-the-art literature surveys covering broader topics. Practical Therapeutics Articles and Leading Articles provide recommendations for specific situations of connections or emerging areas, respectively. The journal publishes: • Original paper • Research Article • Review article • Case study • Clinical study • Literature review • Statistical study The scientific standard of the papers, which are accepted for publication, is controlled by the Editorial Board or by other Experts in the various fields of Pharmacology, Pharmacokinetics and Therapeutics Medicine and Surgery. Submitted papers are subject to a rigorous but rapid peer review process. A first decision is provided to authors approximately in a week after submission and we aim for a review time of two weeks. Acceptance for publication is approximately in 4 weeks. Faster Publication in PHARMAKON- Press’s open access journal is achieved by online availability. The review process is designed to help authors to improve their articles by giving them constructive comments, and we select to publish only those articles which comply to general quality criteria of a scholarly paper, especially originality, clarity, references to related work and validity of results and conclusions.